Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Aortic Stenosis

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Aortic Stenosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Banypersad, SM; Flett, AS; Fontana, M; Maestrini, V; Moon, JC; Neubauer, S; Piechnik, SK; Roberts, N; Sado, DM; White, SK1
Bautz, W; Dobritz, M; Fellner, C; Fellner, F; Janka, R; Lang, W; Lenz, M1

Other Studies

2 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Aortic Stenosis

ArticleYear
Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR.
    Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2012, Dec-28, Volume: 14

    Topics: Adult; Aged; Amyloidosis; Aortic Valve Stenosis; Biopsy; Breath Holding; Cardiomyopathy, Hypertrophic; Case-Control Studies; Collagen; Contrast Media; Female; Fibrosis; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardium; Organometallic Compounds; Predictive Value of Tests; Prospective Studies; Reproducibility of Results; Severity of Illness Index

2012
Gd-BOPTA: "the MRA contrast agent of choice"?
    Rontgenpraxis; Zeitschrift fur radiologische Technik, 1999, Volume: 52, Issue:2

    Topics: Aortic Valve Stenosis; Chelating Agents; Contrast Media; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Angiography; Meglumine; Organometallic Compounds; Subclavian Artery; Vascular Diseases

1999